Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+T-cell responses against influenza virus-Reference-Cited by-同舟云学术

Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+T-cell responses against influenza virus

Published:2014-12-28 Issue:2 Volume:45 Page:624-635
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Fossum Even¹,Grødeland Gunnveig¹,Terhorst Dorothea²³⁴⁵,Tveita Anders A.⁶,Vikse Elisabeth¹,Mjaaland Siri¹⁷,Henri Sandrine³,Malissen Bernard³,Bogen Bjarne¹⁶

Affiliation:

1. K.G. Jebsen Center for Influenza Vaccine Research; Institute of Immunology; University of Oslo and Oslo University Hospital; Oslo Norway

2. Department of Dermatology; Charité University Medicine Berlin; Berlin Germany

3. Centre d'Immunologie de Marseille-Luminy (CIML); Aix-Marseille Université; Marseille France

4. INSERM U1104; Marseille France

5. CNRS UMR7280; Marseille France

6. Center for Immune Regulation; Institute of Immunology; University of Oslo and Oslo University Hospital; Oslo Norway

7. Division for Infectious Disease Control; Department of Bacteriology and Infection Immunology; Norwegian Institute of Public Health; Oslo Norway

Funder

European Communities Framework Program 7

Helse SÃ¸r-Ã˜st

KG Jebsen Foundation

Norwegian Research Council (GLOBVAC)

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201445080/fullpdf

Reference43 articles.

1. Introduction of soluble protein into the class I pathway of antigen processing and presentation;Moore;Cell,1988

2. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8 +dendritic cells;Pooley;J. Immunol.,2001

3. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo;Haan;J. Exp. Med.,2000

4. Antibody-targeted vaccines;Keler;Oncogene,2007

5. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance;Bonifaz;J. Exp. Med.,2002

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice;npj Vaccines;2024-08-14

2. Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response;Vaccines;2024-06-14

3. Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins;Nature Communications;2024-02-12

4. The XCL1-Mediated DNA Vaccine Targeting Type 1 Conventional Dendritic Cells Combined with Gemcitabine and Anti-PD1 Antibody Induces Potent Antitumor Immunity in a Mouse Lung Cancer Model;International Journal of Molecular Sciences;2024-02-04

5. Recombinant antigen delivery to dendritic cells as a way to improve vaccine design;Experimental Biology and Medicine;2023-09-25